can tirzepatide cause birth defects Does Defects? Evidence and Safety Guidance What are the outcomes for

Although the reasons for this are not fully known, increased exposure to oestrogen caused by an earlier age of period onset, higher body mass index and increased use of hormone therapy (such as hormone replacement therapy in postmenopausal women) may contribute

Bottom line Retatrutide is still in clinical trials, with early data suggesting significant weight loss potential, while semaglutide has FDA approval with proven efficacy and safety history

Still, patterns matter. What I Liked About Prime Health Despite the mixed reviews, there are a few things they do well: Transparent pricing no surprises, no upcharges for higher doses Both compounded injectable GLP-1s available Modern, easy-to-navigate patient dashboard Clear plan details before you pay It feels like a legit operation

This makes it valuable for diagnosing and monitoring conditions like obesity, sarcopenia, and metabolic disorders

Gastroenterology 122, 10481057

[DOI] [PubMed] [Google Scholar] 140.Faerch K., Torekov S.S., Vistisen D., Johansen N.B., Witte D.R., Jonsson A., et al